From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease [0.03%]
从肝脏到肠道：儿童代谢功能障碍相关肝脂变病的潜在胃肠道影响
Gianmario Forcina,Vittoria Frattolillo,Maria De Cesare et al.
Gianmario Forcina et al.
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disorder in children and is increasingly recognized as a multisystem condition. Among its extrahepatic man...
Highlighting the relevance of a multidisciplinary approach in metabolic-associated steatotic liver disease (MASLD) [0.03%]
强调代谢相关脂肪性肝病（MAFLD）多学科方法的相关性的研究
Carmen Lara-Romero,Miguel Angel Fernández-Gómez,Franz Martín et al.
Carmen Lara-Romero et al.
Introduction: Metabolic-associated steatotic liver disease (MASLD) represents a prevalent and multifaceted systemic condition, characterized by its intricate interplay of obesity, type 2 diabetes, and various metabolic pe...
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how? [0.03%]
多探测器CT血管造影在非静脉曲张性上消化道出血中的应用：何时、为何及如何应用？
Alberto Martino,Marco Di Serafino,Francesco Manguso et al.
Alberto Martino et al.
Introduction: Non-variceal upper gastrointestinal bleeding (NVUGIB) is a common gastroenterological emergency associated with significant morbidity and mortality. According to current gastroenterological guidelines, esoph...
Altered gastrointestinal motility after bariatric surgery: consequences, complications and clinical considerations [0.03%]
代谢手术后胃肠道动力改变：后果、并发症及临床考虑因素
Gwen M C Masclee,Adrian A M Masclee
Gwen M C Masclee
Introduction: Bariatric surgical interventions such as laparoscopic sleeve gastrectomy (LSG), Roux-en-Y gastric bypass (RYGB), One-Anastomosis Gastric Bypass (OAGB) and Laparoscopic Adjustable Gastric Banding (LAGB) have ...
Nikki Duong,Veronica Nguyen,Mindie Nguyen
Nikki Duong
Introduction: Hepatocellular carcinoma (HCC) is a leading cause of morbidity and mortality in patients with cirrhosis and carries a substantial public health burden. Primary liver cancer is the sixth most common cancer wo...
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges [0.03%]
肠道微生物组作为结直肠癌筛查工具的潜力与挑战
Andrea Severino,Stefano Andrea Marchitto,Piergiorgio Bisegna et al.
Andrea Severino et al.
Introduction: Colorectal cancer (CRC) represents a global public health challenge, ranking as the third most prevalent cancer globally. Population-based screening programs for average-risk populations have proven effectiv...
Diagnostic and therapeutic strategies for biliary strictures: a comparison of ACG, ESGE, and ASGE guidelines [0.03%]
胆道狭窄的诊断和治疗策略：美国胃肠病学院(ACG)、欧洲胃肠内镜学会(ESGE) 和美国胃肠病协会 (ASGE) 指南对比分析
Eyad Gadour,Stefano Francesco Crinò,Marco Spadaccini et al.
Eyad Gadour et al.
Introduction: The diagnostic management of biliary strictures remains a complex clinical challenge requiring evidence-based guidance. Multiple societies, including the European Society of Gastrointestinal Endoscopy (ESGE)...
Miguel Saps,Samantha Arrizabalo
Miguel Saps
Introduction: Abdominal pain disorders (APDs), including irritable bowel syndrome (IBS) and functional abdominal pain - not otherwise specified (FAP), are highly prevalent in children and significantly impact quality of l...
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease [0.03%]
优化抗肿瘤坏死因子治疗克罗恩病和溃疡性结肠炎患者诱导缓解后的维持方案
Ajay Gade,Alessandra Saraga,Tina Deyhim et al.
Ajay Gade et al.
Introduction: Subcutaneous infliximab (SC-IFX) is an efficacious medication for inflammatory bowel disease (IBD). However, there is limited information about treatment optimization following loss of response (LOR), the ro...
André Bargas,Joana Torres,Bram Verstockt
André Bargas
Introduction: Crohn's disease (CD) is a chronic inflammatory condition with a highly variable course and unpredictable treatment response. As the therapeutic landscape expands, there is a growing need for biomarkers that ...